As in JAK2V617F mice, splenomegaly is rare in chronic phase ET patients and the JAK2 mutation is associated with a mild but significant increase in hemoglobin that still lies within the normal range [31]–[33]. This evidence concerns the gene JAK2 and essential thrombocythemia.